These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28397718)

  • 21. Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: a retrospective study.
    Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    BMC Nephrol; 2018 Jul; 19(1):187. PubMed ID: 30064369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of poor prognosis in ANCA-associated vasculitis (AAV): a single-center prospective study of inpatients in China.
    Gao R; Wu Z; Xu X; Pu J; Pan S; Zhang Y; Zhuang S; Yang L; Liang Y; Song J; Tang J; Wang X
    Clin Exp Med; 2023 Aug; 23(4):1331-1343. PubMed ID: 36244021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: a study of 439 cases in a single Chinese center.
    Li ZY; Chang DY; Zhao MH; Chen M
    Arthritis Rheumatol; 2014 Jul; 66(7):1920-6. PubMed ID: 24623469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
    Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
    J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pathological study on patients with primary antineutrophil cytoplasmic autoantibody-associated vasculitis with renal immune complex deposition.
    Li X; Zhang W; Yu HJ; Pan XX; Shen PY; Ren H; Wang WM; Chen N
    J Clin Rheumatol; 2015 Jan; 21(1):3-9. PubMed ID: 25539426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.
    Gregersen JW; Kristensen T; Krag SR; Birn H; Ivarsen P
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S39-47. PubMed ID: 22510451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study.
    Yang L; Xie H; Liu Z; Chen Y; Wang J; Zhang H; Ge Y; Hu W
    BMC Nephrol; 2018 Jun; 19(1):138. PubMed ID: 29902982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
    Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
    BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Gopaluni S; Flossmann O; Little MA; O'Hara P; Bekker P; Jayne D;
    Arthritis Rheumatol; 2019 May; 71(5):784-791. PubMed ID: 30418705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral candidiasis is a significant predictor of subsequent severe infections during immunosuppressive therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Yamaguchi M; Katsuno T; Iwagaitsu S; Nobata H; Kinashi H; Banno S; Ito Y
    BMC Infect Dis; 2019 Jul; 19(1):664. PubMed ID: 31349802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis.
    Ford SL; Polkinghorne KR; Longano A; Dowling J; Dayan S; Kerr PG; Holdsworth SR; Kitching AR; Summers SA
    Am J Kidney Dis; 2014 Feb; 63(2):227-35. PubMed ID: 24183110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts.
    Pagnoux C; Hogan SL; Chin H; Jennette JC; Falk RJ; Guillevin L; Nachman PH
    Arthritis Rheum; 2008 Sep; 58(9):2908-18. PubMed ID: 18759282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of disease activities and extent measurements for anti-neutrophil cytoplasmic autoantibody-associated vasculitis].
    Li SG; Zhang Q; Zhou HQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1022-1026. PubMed ID: 30562775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Outcomes of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Patients Over Age 75 Years: A Meta-Analysis.
    Morris AD; Elsayed ME; Ponnusamy A; Rowbottom A; Martin F; Geetha D; Dhaygude AP
    Am J Nephrol; 2020; 51(4):327-336. PubMed ID: 32160625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study.
    Ma Y; Han F; Chen L; Wang H; Han H; Yu B; Xu Y; Chen J
    BMC Nephrol; 2017 Dec; 18(1):381. PubMed ID: 29287586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Birmingham vasculitis activity and chest manifestation at diagnosis can predict hospitalised infection in ANCA-associated vasculitis.
    Yoo J; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2018 Aug; 37(8):2133-2141. PubMed ID: 29557539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of low serum complement C3 with reduced patient and renal survival in antimyeloperoxidase-associated small-vessel vasculitis.
    Molad Y; Tovar A; Ofer-Shiber S
    Nephron Clin Pract; 2014; 126(1):67-74. PubMed ID: 24577364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal vasculitis presenting with acute kidney injury.
    Villacorta J; Diaz-Crespo F; Acevedo M; Cavero T; Guerrero C; Praga M; Fernandez-Juarez G
    Rheumatol Int; 2017 Jun; 37(6):1035-1041. PubMed ID: 28289874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.